Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

AI gaining ground in electrophysiology, but clinicians still run the show
Even as AI is used more and more in the field, cardiologists and other clinicians are at the heart of patient care.
Biotech company receives second grant to develop gene therapy for AFib
The therapy, if successful, could eliminate the need for patients to take drugs or undergo invasive catheter ablation procedures.
Johnson & Johnson appears to exit LAA closure market, selling heart tech to new startup
Johnson & Johnson is selling key assets related to its Laminar program to a new startup, Jaguar LAA. This comes less than three years after Johnson & Johnson acquired Laminar for $400 million.
FDA approves smaller leadless pacemaker from Abbott
The newly approved device is 14% shorter than the previous version and gives clinicians more options when making implant decisions.
Stryker recalls AEDs due to malfunction risk
If a malfunction does occur, Stryker warned, it could impact the device's effectiveness. No adverse events have been reported at this time.

Riata, TAVR & legacies

Are Riata concerns a thing of the past and transcatheter aortic valve replacement (TAVR) for almost anyone with severe aortic stenosis the way of the future? Presentations at recent cardiology conferences addressed those questions.

HRS statement recommends remote monitoring as standard of care

A panel of experts recommended that remote monitoring become the standard of care for patients with cardiovascular implantable electronic devices (CIEDs), according to a consensus statement from the Heart Rhythm Society (HRS). The statement was published online in Heart Rhythm on May 13.

Data shows the CardioMEMS HF System adds incremental benefit when combined with device therapy and is cost effective

St. Jude Medical, Inc., a global medical device company, today announced important new data presented during the Heart Rhythm Society's (HRS) 36th annual Scientific Session supporting improved outcomes and cost-effectiveness of the CardioMEMS™ HF System for the management of Class III heart failure patients.

At Heart Rhythm 2015, an international panel of experts provides concise diagnosis and treatment recommendations to improve quality of care for patients with specific cardiovascular syndromes

The Heart Rhythm Society (HRS) has released a first-of-its-kind expert consensus statement on three specific cardiovascular disorders that also involve the autonomic nervous system. The 2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope was written by an international group of experts and presented today at Heart Rhythm 2015, the Heart Rhythm Society’s 36th Annual Scientific Sessions.

Accreditation for Cardiovascular Excellence (ACE) publishes new standards for electrophysiology (EP) and implantable cardioverter defibrillators (ICD)

Accreditation for Cardiovascular Excellence (ACE) has just released the first-ever electrophysiology (EP) and Implantable Cardioverter Defibrillator (ICD) standards for accreditation. Driven by the latest available clinical evidence, the EP and ICD standards are a comprehensive review of interventional procedures in patients and adults with heart rhythm disorders.

Boston Scientific announces scheduled presentations at Heart Rhythm Society 2015

Boston Scientific today announced that key data from 42 abstracts will be featured at the 36th Annual Scientific Sessions of the Heart Rhythm Society (HRS) in Boston on May 13-16.

Medtronic to unveil first-of-its-kind clinical data for cardiac therapies at Heart Rhythm 2015

Medtronic plc today announced its schedule of notable clinical studies that will be presented at Heart Rhythm 2015, the Heart Rhythm Society's 36th Annual Scientific Sessions in Boston, including two late-breaking clinical trials featuring the Evera MRI® SureScan® implantable cardioverter-defibrillator (ICD) System and Micra® Transcatheter Pacing System (TPS).

Get ready for SCAI, HRS

This is the month for subspecialty cardiology conferences in the U.S., with two major meetings setting anchors on each coast.

Around the web

Radiology Business

Imaging artificial intelligence vendor Elucid raises $55M

Radiology Business

Cardiac CT's expanding role gives radiologists new opportunities

Electrophysiology

AI gaining ground in electrophysiology, but clinicians still run the show

Biotech company receives second grant to develop gene therapy for AFib

Johnson & Johnson appears to exit LAA closure market, selling heart tech to new startup

FDA approves smaller leadless pacemaker from Abbott

Stryker recalls AEDs due to malfunction risk

Around the web